tiprankstipranks
Pliant Therapeutics (PLRX)
NASDAQ:PLRX
US Market

Pliant Therapeutics (PLRX) Financial Statements

Compare
508 Followers

Pliant Therapeutics Financial Overview

Pliant Therapeutics's market cap is currently $82.67M. The company's EPS TTM is $-3.473; its P/E ratio is ―; Pliant Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 1.58M$ 9.69M$ 7.57M$ 41.82M
Gross Profit$ 0.00$ 1.58M$ 6.00M$ 4.37M$ 41.82M
Operating Income$ -228.37M$ -184.15M$ -127.20M$ -19.99M$ -41.65M
EBITDA$ -228.37M$ -158.23M$ -118.85M$ -95.73M$ -40.34M
Net Income$ -210.30M$ -161.34M$ -121.50M$ -17.91M$ -39.74M
Balance Sheet
Cash & Short-Term Investments$ 355.72M$ 494.25M$ 331.19M$ 200.60M$ 276.89M
Total Assets$ 396.95M$ 512.15M$ 350.61M$ 221.22M$ 295.53M
Total Debt$ 29.98M$ 11.37M$ 15.81M$ 7.19M$ 283.00K
Net Debt$ -41.21M$ -51.86M$ -17.87M$ -44.47M$ -50.60M
Total Liabilities$ 92.87M$ 38.58M$ 37.27M$ 22.16M$ 12.46M
Stockholders' Equity$ 304.08M$ 473.58M$ 313.34M$ 199.06M$ 283.06M
Cash Flow
Free Cash Flow$ -159.35M$ -117.28M$ -96.39M$ -77.40M$ -38.80M
Operating Cash Flow$ -155.50M$ -116.36M$ -94.63M$ -75.44M$ -37.27M
Investing Cash Flow$ 140.34M$ -127.01M$ -150.20M$ 73.70M$ -210.87M
Financing Cash Flow$ 23.12M$ 274.40M$ 226.85M$ 2.53M$ 213.21M
Currency in USD

Pliant Therapeutics Earnings and Revenue History

Pliant Therapeutics Debt to Assets

Pliant Therapeutics Cash Flow

Pliant Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis